US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

fentaNYL 400 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1440-76 D-0554-2020
Class II · Moderate risk Terminated

fentaNYL 2500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1093-37 D-0553-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1225-37 D-0552-2020
Class II · Moderate risk Terminated

fentaNYL 1500 mcg/30 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1099-49 D-0551-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1104-36 D-0550-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1269-37 D-0549-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1259-75 D-0548-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1105-37 D-0547-2020
Class II · Moderate risk Terminated

fentaNYL 500 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1160-37 D-0546-2020
Class II · Moderate risk Terminated

Albuterol 1.25mg / Ipratropium 0.5mg

Reason Lack of Processing Controls

Integrated Health Concepts Inc. dba Conversio Health D-0515-2020
Class II · Moderate risk Terminated

Albuterol 2.5mg / Budesonide 0.5mg

Reason Lack of Processing Controls

Integrated Health Concepts Inc. dba Conversio Health D-0513-2020
Class II · Moderate risk Terminated

Albuterol 2.5mg / Ipratropium 0.75mg

Reason Lack of Processing Controls

Integrated Health Concepts Inc. dba Conversio Health D-0510-2020
Class II · Moderate risk Terminated

Albuterol 3.75mg / Ipratropium 0.75mg

Reason Lack of Processing Controls

Integrated Health Concepts Inc. dba Conversio Health D-0509-2020
Class II · Moderate risk Terminated

Budesonide 0.4mg

Reason Lack of Processing Controls

Integrated Health Concepts Inc. dba Conversio Health D-0508-2020
Class II · Moderate risk Terminated

Formoterol 12mcg / Budesonide 0.5mg

Reason Lack of Processing Controls

Integrated Health Concepts Inc. dba Conversio Health D-0507-2020
Class II · Moderate risk Terminated

Lidocaine HCl Injection

Reason Presence of Foreign Substance: Foreign material found inside the vial.

AuroMedics Pharma LLC NDC 55150-165-05 D-0573-2020
Class II · Moderate risk Terminated

R2103

Reason CGMP Deviations: products were not manufactured under current good manufacturing practices.

Washington Homeopathic Products, Inc. D-0506-2020
Class II · Moderate risk Terminated

StellaLife VEGA Oral Gel Rinse

Reason CGMP Deviations: products were not manufactured under current good manufacturing practices.

Washington Homeopathic Products, Inc. D-0505-2020
Class II · Moderate risk Terminated

Pareira

Reason CGMP Deviations: products were not manufactured under current good manufacturing practices.

Washington Homeopathic Products, Inc. D-0504-2020
Class II · Moderate risk Terminated

Silicea 6X Tablets

Reason CGMP Deviations: products were not manufactured under current good manufacturing practices.

Washington Homeopathic Products, Inc. D-0503-2020
Class II · Moderate risk Terminated

Natrum Sulphuricum 6X Tablets

Reason CGMP Deviations: products were not manufactured under current good manufacturing practices.

Washington Homeopathic Products, Inc. D-0502-2020